Literature DB >> 24316747

The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors.

Suerda Guiomar Feijó, José Milton de Castro Lima, Maria Aparecida Alves de Oliveira, Régia Maria Vidal Patrocínio, Luis Gonzaga Moura-Junior, Antônio Borges Campos, José Wellington Oliveira Lima, Lúcia Libanez Bessa Campelo Braga.   

Abstract

PURPOSE: To determine the prevalence of non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery and to identify risk factors associated with the disease spectrum.
METHODS: Liver biopsy was performed in 60 patients who underwent bariatric surgery, after other causes of liver disease were excluded. Clinical, biochemical and histological features were evaluated.
RESULTS: NAFLD was detected in fifty-seven patients (95%) of the sample and forty patients (66.7%) of the total sample met the criteria for NASH. Perisinusoidal fibrosis was only found in three (7.5%) patients with NASH. The γGT was an independent predictive factor associated with the degree of hepatic steatosis. The variables such as dyslipidemia and ALT were independently associated with the presence of Mallory's corpuscles with the following values, respectively, OR 0, 05, 95% CI 0.002 to 0.75, P = 0.031 and OR 10, 99, 95% CI 1.44 to 83.93, P = 0.021.
CONCLUSIONS: Non alcoholic fatty liver disease seems to be an obese-related condition with approximately half of asymptomatic morbidly obese patients having histological NASH. The γGT was an independent predictor of the degree of steatosis.

Entities:  

Mesh:

Year:  2013        PMID: 24316747     DOI: 10.1590/s0102-86502013001100008

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  10 in total

Review 1.  Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

Authors:  Sonia Roman; Claudia Ojeda-Granados; Omar Ramos-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.

Authors:  Shinhiti Morita; Dalísio De Santi Neto; Flávio Hiroshi Ananias Morita; Nina Kimie Morita; Suzana Margareth Ajeje Lobo
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

3.  Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.

Authors:  Yun-Hua Li; Lu-Hua Yang; Kai-Hui Sha; Tong-Gang Liu; Li-Guo Zhang; Xian-Xian Liu
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 4.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

5.  Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.

Authors:  Iria Cebreiros López; Florentina Guzmán Aroca; Maria Dolores Frutos Bernal; Juan Antonio Luján Mompeán; Águeda Bas Bernal; Antonio Miguel Hernández Martínez; Enrique Martínez Barba; Jose Antonio Noguera Velasco; Pascual Parilla Paricio
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

6.  Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.

Authors:  Anshuman Elhence; Bhavik Bansal; Hardik Gupta; Abhinav Anand; Thakur P Singh; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-11-25

7.  Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese.

Authors:  Geraldine J Ooi; Paul R Burton; Lisa Doyle; John M Wentworth; Prithi S Bhathal; Ken Sikaris; Michael A Cowley; Stuart K Roberts; William Kemp; Paul E O'Brien; Wendy A Brown
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

8.  COMPARISON OF HEPATIC PROFILE IN PRE AND POSTOPERATIVE OF BARIATRIC SURGERY: PRIVATE VS PUBLIC NETWORK.

Authors:  Taianne Machado Nascimento; Antônio Alves-Júnior; Marco Antonio Prado Nunes; Tiago Rodrigo Pereira de Freitas; Marco Antonio Fontes Sarmento da Silva; Maria Rosa Melo Alves
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

9.  HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.

Authors:  Changxi Chen; Zhongwei Zhu; Yushan Mao; Yimin Xu; Juan Du; Xiaoping Tang; Hongbao Cao
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

10.  Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Saleh A Alqahtani; Pegah Golabi; James M Paik; Brian Lam; Amir H Moazez; Hazem A Elariny; Zachary Goodman; Zobair M Younossi
Journal:  Obes Surg       Date:  2021-02-22       Impact factor: 4.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.